Company Profiles

driven by the PitchBook Platform

AmVac

Description

Developer of vaccines. The company develops innovative and safe vaccines that enhance human health and improve scientific understanding of immunological conditions and focuses on the fast growing vaccine market in the fields of gynecology, urology and lung diseases.

2005

Founded

PRIVATE

Status

11-50

Employees

Grant

Latest Deal Type

$15.2M

Latest Deal Amount

$4M

Total Amount Raised

Description

Developer of vaccines. The company develops innovative and safe vaccines that enhance human health and improve scientific understanding of immunological conditions and focuses on the fast growing vaccine market in the fields of gynecology, urology and lung diseases.

Website:

www.amvac.eu

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Primary Office

Baarerstrasse 22 6300 ZugSwitzerland +41 (0)41 725 3230
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore AmVac's full profile, request a free trial.

AmVac Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

AmVac Investors (2)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
European Union Seventh Framework ProgrammeOther000 0000000 0000
V+ ManagementVenture CapitalMinority000 0000000 0000
European Union Seventh Framework Programme Other
V+ Management Venture Capital

AmVac Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Ali PashazadehChief Executive Officer
Marian WiegandHead, Research & Development
Ali Pashazadeh Chief Executive Officer
Marian Wiegand Head, Research & Development

AmVac Board Members (2)

NameRepresentingRoleSinceContact
Info
Keith LuxonSelfPresident, Supervisory Board000 0000
Viktor SauterSelfBoard Member000 0000
Keith Luxon President, Supervisory Board Self
Viktor Sauter Board Member Self
Request full access to PitchBook